Welcome to the Settlement website for In re Salix Pharmaceuticals Ltd., pending in the United States District Court for the Southern District of New York (the “Action”).
The Court-appointed Lead Plaintiff, the Pentwater Funds, on behalf of itself and the other members of the Settlement Class (defined below), has reached a proposed settlement of this Action with defendant Salix Pharmaceuticals, Ltd. (“Salix”) and defendants Carolyn J. Logan and Adam C. Derbyshire for $210,000,000 in cash that, if approved, will resolve all claims in the Action (the “Settlement”).
If you are a member of the Settlement Class, your rights will be affected and you may be eligible for a payment from the Settlement. The Settlement Class consists of:
all persons or entities who purchased or otherwise acquired publicly traded Salix common stock or publicly traded call options on Salix common stock, or sold publicly traded put options on Salix common stock, during the period from November 8, 2013 through November 6, 2014, inclusive (the “Class Period”), and were damaged thereby, except for certain persons and entities who are excluded from the Settlement Class by definition (see paragraph 21 of the Notice) or who request exclusion pursuant to the instructions set forth in the Notice.
If you are a member of the Settlement Class, in order to be potentially eligible to receive a payment under the proposed Settlement, you must submit a Claim Form postmarked no later than August 9, 2017. Payments to eligible claimants will be made only if the Court approves the Settlement and a plan of allocation, and only after any appeals are resolved, and after the completion of all claims processing. Please be patient, as this process will take some time to complete.
IMPORTANT DATES AND DEADLINES
|August 9, 2017||Claim Filing Deadline. Claim Forms must be postmarked no later than August 9, 2017 to be eligible for a payment from the Settlement.|
|July 5, 2017||Exclusion Deadline. To exclude yourself from the Settlement Class, you must submit a written request for exclusion so that it is received no later than July 5, 2017, in accordance with the instructions in the Notice.|
|July 5, 2017||Objection Deadline. Any objections to the proposed Settlement, the proposed Plan of Allocation, or the request for attorneys’ fees and reimbursement of Litigation Expenses, must be received no later than July 5, 2017, in accordance with the instructions in the Notice.|
|July 24, 2017
at 11:00 a.m.
|Settlement Hearing. The Settlement Hearing will be held on July 24, 2017 at 11:00 a.m., before the Honorable Kimba M. Wood in Courtroom 18B of the United States District Court for the Southern District of New York, Daniel Patrick Moynihan United States Courthouse, 500 Pearl St., New York, NY 10007-1312, to determine, among other things, whether the proposed Settlement is fair, reasonable and adequate and should be approved; whether the proposed Plan of Allocation is fair and reasonable and should be approved; and whether Lead Counsel’s motion for an award of attorneys’ fees and reimbursement of Litigation Expenses should be approved.|